Guyana Gold Corp
Guyana Gold Corp., a junior mineral exploration company, engages in the identification, acquisition, and development of precious and base metal properties in the Caribbean. It primarily focuses on gold, diamond, bauxite, and semiprecious stones. The company holds a 50% working interest in various mineral projects comprising 6 blocks located along the Guyana Shield region of Port Kaituma in Guyana… Read more
Guyana Gold Corp (GYGC) - Net Assets
Latest net assets as of June 2024: $-286.49K USD
Based on the latest financial reports, Guyana Gold Corp (GYGC) has net assets worth $-286.49K USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.65K) and total liabilities ($291.14K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-286.49K |
| % of Total Assets | -6165.12% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Guyana Gold Corp - Net Assets Trend (2022–2023)
This chart illustrates how Guyana Gold Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Guyana Gold Corp (2022–2023)
The table below shows the annual net assets of Guyana Gold Corp from 2022 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-271.91K | -146.93% |
| 2022-12-31 | $-110.12K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Guyana Gold Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 43224500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $109.29K | % |
| Other Components | $100.81K | % |
| Total Equity | $-275.14K | 100.00% |
Guyana Gold Corp Competitors by Market Cap
The table below lists competitors of Guyana Gold Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BC Craft Supply Co. Ltd
PINK:CRFTF
|
$22.00 |
|
Tribe Technology PLC
LSE:TRYB
|
$22.04 |
|
Mymetics Corp
PINK:MYMX
|
$22.08 |
|
MIWA SUGAR LIMITED
SEM:MIWA
|
$22.08 |
|
HYBRIGENICS A-
BE:3HB
|
$21.76 |
|
BOOHOO GROUP PLC
LSE:DEBS
|
$21.46 |
|
Paragon Shipping Inc
PINK:PRGNF
|
$21.34 |
|
Naeem Holding
EGX:NAHO
|
$21.13 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guyana Gold Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -110,118 to -275,145, a change of -165,027.
- Net loss of 165,027 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-165.03K | -59.98% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Guyana Gold Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $0.04 | $0.00 | x |
| 2006-12-31 | $-0.50 | $0.00 | x |
| 2007-12-31 | $-0.76 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guyana Gold Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-118.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -590.59% | 0.00% | 0.00x | 1.00x | $-51.05K |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-40.16K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-35.14K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-99.11K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-137.51K |
Industry Comparison
This section compares Guyana Gold Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guyana Gold Corp (GYGC) | $-286.49K | -590.59% | N/A | $21.85 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |